Healthcare - Biotechnology - NASDAQ - US
$ 2.67
-4.98 %
$ 755 M
Market Cap
-2.87
P/E
BALANCE SHEET
395 M
ASSETS
78.6 M
LIABILITIES
317 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Erasca, Inc.
| Current Assets | 321 M |
| Cash & Short-Term Investments | 312 M |
| Receivables | 0 |
| Other Current Assets | 8.33 M |
| Non-Current Assets | 74.6 M |
| Long-Term Investments | 10 M |
| PP&E | 60.2 M |
| Other Non-Current Assets | 4.38 M |
| Current Liabilities | 26.2 M |
| Accounts Payable | 2 M |
| Short-Term Debt | 7.94 M |
| Other Current Liabilities | 16.2 M |
| Non-Current Liabilities | 52.5 M |
| Long-Term Debt | 104 M |
| Other Non-Current Liabilities | -51.3 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 93.1 | 284.2 | 360.5 | 65.4 | 29.6 |
| Short Term Investments | 219.3 | 151.4 | 54.0 | 53.3 | 20.8 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 8.3 | 8.9 | 11.1 | 2.6 | 1.5 |
| Total Current Assets | 320.7 | 444.5 | 420.0 | 120.0 | 51.1 |
| PP&E | 60.2 | 65.2 | 33.3 | 4.1 | 4.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 10.1 | 0.4 | 44.8 | 0.3 | 0 |
| Other Long Term Assets | 4.4 | 4.8 | 3.3 | 0.5 | 56 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 395.3 | 514.9 | 501.4 | 124.8 | 55.5 |
| LIABILITIES | |||||
| Accounts Payable | 2.0 | 23.0 | 4.7 | 0.9 | 1.4 |
| Short Term Debt | 7.9 | 2.6 | 0.6 | 0.9 | 0.7 |
| Other Current Liabilities | 16.2 | 23.0 | 21.1 | 11.9 | 0.6 |
| Total Current Liabilities | 26.2 | 48.7 | 26.4 | 13.7 | 2.8 |
| Long Term Debt | 103.8 | 107.6 | 37.0 | 2.1 | 3.0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | (51.3) | (53.2) | (18.5) | 223.0 | 63.4 |
| Total Liabilities | 78.6 | 103.1 | 44.9 | 238.8 | 69.1 |
| EQUITY | |||||
| Common Stock | 15 K | 15 K | 12 K | 3 K | 3 K |
| Retained Earnings | (606.0) | (481.0) | (238.2) | (115.4) | (13.7) |
| Other Accumulative Comprehensive Income/Loss | 77 K | (1.0) | (0.2) | 2 K | 11 K |
| Total Equity | 316.7 | (481.0) | (238.2) | (114.0) | (13.6) |
| Total Liabilities and Equity | 395.3 | (377.9) | (193.3) | 124.8 | 55.5 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 150.2 | 122.0 | 119.1 | 119.0 | 119.0 |